VFF

Village Farms ($VFF) CEO's Dramatic U-Turn: From Massive Sales to 100K Share Buying Spree in 8 Months

06/02/2025 11:43

Village Farms International ($VFF) CEO Michael DeGiglio's dramatic investment reversal has captured market attention. After selling over 400,000 shares in September 2024, causing market concern, he aggressively purchased 100,000 shares in May 2025, just eight months later, demonstrating strong confidence in the company. This insider trading pattern reversal shows remarkable synchronization with $VFF's stock movement. The stock started at $1.12 in June 2024, experienced a prolonged decline to $0.48 in April 2025, then staged a dramatic 80%+ recovery to $1.24 in May. Notably, during the CEO's consecutive purchases from May 16-30, the stock rose 13% from $1.05 to $1.19. DeGiglio's buying was highly aggressive. He purchased 10,000 shares ($10,381) on May 16, 5,000 shares ($5,175) on May 19, 30,000 shares ($34,131) on May 20, 10,000 shares ($11,200) on May 21, 20,000 shares ($24,960) on May 23, and 25,000 shares ($30,250) on May 28. His average purchase price ranged from $1.03-$1.25, closely matching current price levels. CFO Stephen Ruffini reinforced management confidence by purchasing 25,000 shares ($30,150) on May 30. This confident insider buying correlates with Village Farms' strategic transformation. In May 2025, the company divested its fresh produce business to Vanguard Food LP, securing $40 million in cash. This marks a pivotal shift from traditional greenhouse vegetable production to becoming a focused global cannabis operator. $VFF currently operates one of the world's largest greenhouse cannabis facilities (2.2 million sq ft) in Canada through Pure Sunfarms, expanding medical cannabis exports to Germany, the UK, and Australia. Q3 2024 exports surged 111% year-over-year, highlighting strong international growth momentum. The company is also entering European recreational markets through Leli Holland in the Netherlands and planning U.S. THC market entry using Texas greenhouse assets. Financially, challenges remain. While 2024 revenue increased 18% to $336.2 million, the company posted a $35.9 million net loss. However, positive operating cash flow ($4.02 million) and levered free cash flow ($11.27 million) demonstrate operational resilience. The debt-to-equity ratio remains manageable at 21.20%. Analysts remain optimistic about $VFF, maintaining an average price target of $2.00, suggesting 68% upside potential from current levels. The cannabis business projects 6.8% annual growth, significantly outpacing the 2.2% average for the U.S. food industry. The company ranked sixth among hedge fund-favored marijuana stocks in late 2024, with notable institutional investors including Renaissance Technologies, indicating potential for continued institutional inflows. However, investors should note risks including high volatility (beta 2.23) and Nasdaq listing maintenance requirements (extended until October 2025). Regulatory uncertainties in the cannabis industry also persist. Despite these challenges, the CEO's dramatic buying reversal, strategic business restructuring, and growing momentum in international cannabis markets brighten $VFF's medium-to-long-term outlook. The market will be watching how insider confidence translates into operational execution and profitability.

You can receive notifications when news is published.